HDL and macrophages: explaining the clinical failures and advancing HDL-based therapeutics in cardiovascular diseases?

Emiel P. C. van der Vorst*, Kosta Theodorou, Erik A. L. Biessen, Marjo M. P. C. Donners

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)343-344
Number of pages2
JournalExpert review of cardiovascular therapy
Volume15
Issue number5
DOIs
Publication statusPublished - 2017

Keywords

  • High density lipoproteins
  • macrophages
  • inflammation
  • atherosclerosis
  • INFLAMMATION
  • RISK

Cite this